Chiron announces preliminary results from genital herpes immunotherapy trial.EMERYVILLE, Calif.--(BUSINESS WIRE)--Jan. 8, 1996--Chiron Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CHIR CHIR Chiricahua National Monument (US National Park Service) ) announced today that based on a preliminary review of data from a clinical trial, an immunotherapeutic agent for genital herpes Genital Herpes Definition Genital herpes is a sexually transmitted disease caused by a herpes virus. The disease is characterized by the formation of fluid-filled, painful blisters in the genital area. had a statistically significant benefit on several disease indicators but did not reach statistical significance on its primary endpoint. Chiron continues to analyze the results of the trial. The complete result will be reported by clinical investigators in an appropriate scientific forum. Chiron Corporation is a diversified, science-driven healthcare company that combines diagnostic, vaccine and therapeutic strategies for managing disease. Chiron participates in four global healthcare markets: diagnostics, including immunodiagnostics, critical care diagnostics and new quantitative probe tests; therapeutics, with an emphasis on oncology and infectious disease Infectious disease A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions. ; pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children. pe·di·at·ric adj. Of or relating to pediatrics. and adult vaccines; and opthalmic surgical products for the correction of vision. Chiron also has research programs underway in gene therapy and gene transfer, combinatorial chemistry, cardiovascular disease and critical care. CONTACT: Chiron Corporation, Emeryville Larry Kurtz, 510/601-2476 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion